119 related articles for article (PubMed ID: 16373593)
21. The effect of sildenafil on the altered thoracic aorta smooth muscle responses in rat pre-eclampsia model.
Turgut NH; Temiz TK; Bagcivan I; Turgut B; Gulturk S; Karadas B
Eur J Pharmacol; 2008 Jul; 589(1-3):180-7. PubMed ID: 18538317
[TBL] [Abstract][Full Text] [Related]
22. Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat.
Ni XP; Safai M; Rishi R; Baylis C; Humphreys MH
J Am Soc Nephrol; 2004 May; 15(5):1254-60. PubMed ID: 15100365
[TBL] [Abstract][Full Text] [Related]
23. Effects of phosphodiesterase 5 inhibitor on pulmonary vascular reactivity in the fetal lamb.
Jaillard S; Larrue B; Deruelle P; Delelis A; Rakza T; Butrous G; Storme L
Ann Thorac Surg; 2006 Mar; 81(3):935-42. PubMed ID: 16488698
[TBL] [Abstract][Full Text] [Related]
24. Haemodynamic and renal evolution of the bile duct-ligated rat.
Martínez-Prieto C; Ortíz MC; Fortepiani LA; Ruiz-Maciá J; Atucha NM; García-Estañ J
Clin Sci (Lond); 2000 May; 98(5):611-7. PubMed ID: 10781394
[TBL] [Abstract][Full Text] [Related]
25. Chronic hypoxia attenuates cGMP-dependent pulmonary vasodilation.
Jernigan NL; Resta TC
Am J Physiol Lung Cell Mol Physiol; 2002 Jun; 282(6):L1366-75. PubMed ID: 12003794
[TBL] [Abstract][Full Text] [Related]
26. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
Angeli P; Jiménez W; Veggian R; Fasolato S; Volpin R; MacHenzie HS; Craighero R; Libera VD; Sticca A; Arroyo V; Gatta A
Hepatology; 2000 Feb; 31(2):304-10. PubMed ID: 10655250
[TBL] [Abstract][Full Text] [Related]
27. A xanthine-based KMUP-1 with cyclic GMP enhancing and K(+) channels opening activities in rat aortic smooth muscle.
Wu BN; Lin RJ; Lin CY; Shen KP; Chiang LC; Chen IJ
Br J Pharmacol; 2001 Sep; 134(2):265-74. PubMed ID: 11564644
[TBL] [Abstract][Full Text] [Related]
28. Increased phosphodiesterase-5 expression is involved in the decreased vasodilator response to nitric oxide in cirrhotic rat livers.
Loureiro-Silva MR; Iwakiri Y; Abraldes JG; Haq O; Groszmann RJ
J Hepatol; 2006 May; 44(5):886-93. PubMed ID: 16545481
[TBL] [Abstract][Full Text] [Related]
29. Vascular hyporesponsiveness in aortic rings from cirrhotic rats: role of nitric oxide and endothelium.
Ortíz MC; Fortepiani LA; Martínez C; Atucha NM; García-Estañ J
Clin Sci (Lond); 1996 Dec; 91(6):733-8. PubMed ID: 8976809
[TBL] [Abstract][Full Text] [Related]
30. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
Eckly AE; Lugnier C
Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
[TBL] [Abstract][Full Text] [Related]
31. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
Kloner RA
Am J Cardiol; 2005 Dec; 96(12B):42M-46M. PubMed ID: 16387566
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological profile of T-1032, a novel specific phosphodiesterase type 5 inhibitor, in isolated rat aorta and rabbit corpus cavernosum.
Takagi M; Mochida H; Noto T; Yano K; Inoue H; Ikeo T; Kikkawa K
Eur J Pharmacol; 2001 Jan; 411(1-2):161-168. PubMed ID: 11137871
[TBL] [Abstract][Full Text] [Related]
33. cAMP modulates cGMP-mediated cerebral arteriolar relaxation in vivo.
Xu HL; Wolde HM; Gavrilyuk V; Baughman VL; Pelligrino DA
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2501-9. PubMed ID: 15271668
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of nitric oxide generation unmasks vascular dysfunction in insulin-resistant, obese JCR:LA-cp rats.
McKendrick JD; Salas E; Dubé GP; Murat J; Russell JC; Radomski MW
Br J Pharmacol; 1998 May; 124(2):361-9. PubMed ID: 9641554
[TBL] [Abstract][Full Text] [Related]
35. Tolerance to relaxation in rat aorta: comparison of an S-nitrosothiol with nitroglycerin.
Kowaluk EA; Poliszczuk R; Fung HL
Eur J Pharmacol; 1987 Dec; 144(3):379-83. PubMed ID: 3126076
[TBL] [Abstract][Full Text] [Related]
36. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
[TBL] [Abstract][Full Text] [Related]
37. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.
Trebicka J; Leifeld L; Hennenberg M; Biecker E; Eckhardt A; Fischer N; Pröbsting AS; Clemens C; Lammert F; Sauerbruch T; Heller J
Hepatology; 2008 Apr; 47(4):1264-76. PubMed ID: 18318439
[TBL] [Abstract][Full Text] [Related]
38. Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta.
Mochida H; Inoue H; Takagi M; Noto T; Yano K; Kikkawa K
Eur J Pharmacol; 2002 Apr; 440(1):45-52. PubMed ID: 11959087
[TBL] [Abstract][Full Text] [Related]
39. Change in lipid profile and impairment of endothelium-dependent relaxation of blood vessels in rats after bile duct ligation.
Ji H; Jiang JY; Xu Z; Kroeger EA; Lee SS; Liu H; Shen H; Zhang M; Minuk GY; Choy PC; Gong Y
Life Sci; 2003 Jul; 73(10):1253-63. PubMed ID: 12850241
[TBL] [Abstract][Full Text] [Related]
40. Effects of metabolic inhibitors on endothelium-dependent and endothelium-independent vasodilatation of rat and rabbit aorta.
Weir CJ; Gibson IF; Martin W
Br J Pharmacol; 1991 Jan; 102(1):162-6. PubMed ID: 1646055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]